Quantedge Capital Pte LTD Collegium Pharmaceutical, Inc Transaction History
Quantedge Capital Pte LTD
- $328 Million
- Q3 2024
A detailed history of Quantedge Capital Pte LTD transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Quantedge Capital Pte LTD holds 338,200 shares of COLL stock, worth $10.4 Million. This represents 3.99% of its overall portfolio holdings.
Number of Shares
338,200
Previous 291,400
16.06%
Holding current value
$10.4 Million
Previous $9.38 Million
39.27%
% of portfolio
3.99%
Previous 3.49%
Shares
3 transactions
Others Institutions Holding COLL
# of Institutions
252Shares Held
37.5MCall Options Held
100KPut Options Held
10K-
Black Rock Inc. New York, NY5.79MShares$179 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$81.2 Million1.79% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.35MShares$72.3 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.14MShares$66 Million0.15% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.66MShares$51 Million0.1% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.05B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...